About this item:

395 Views | 530 Downloads

Author Notes:

Email: acakmak3@gatech.edu

Subjects:

Research Funding:

The authors wish to acknowledge the support of the National Science Foundation Award 1636933, NIH/NHLBI award K23 127251 and the Georgia Research Alliance.

Keywords:

  • Heart failure
  • mobile health (mHealth)
  • regres- sion
  • actigraphy
  • geolocation
  • social interaction

Personalized heart failure severity estimates using passive smartphone data

Tools:

Conference Name:

2018 IEEE International Conference on Big Data

Publisher:

Conference Place:

Seattle, WA, USA

Publication Date:

Type of Work:

Conference | Final Publisher PDF

Abstract:

Abstract —Heart failure (HF) is one of the leading causes of mortality in the United States with a high economic burden due to readmissions. We present a novel approach to remotely monitor quality of life in patients with HF using a smartphone app and a scalable cloud-based architecture. In a preliminary study, we assess continuous data from 10 HF subjects over a period of up to a year. Over 680 million samples of physical movement data, 9,000 geographic location updates, and 11,000 individual contact activity/diversity events in the form of phone calls were captured from the app. Personalized models were constructed from these data to estimate self-reported quality of life using the Kansas City Cardiomyopathy Questionnaire (KCCQ), which has been shown to be a reliable health status measure for HF patients. Generalized linear models using only motion features were shown to reliably estimate the KCCQ score with an out of sample mean absolute error of 5.71%. Personalized models for estimating the HF severity as mild or severe were also built as a proof of concept to detect when a subject’s data indicated a clinical deterioration. Average out of sample accuracy was 83% for this binary classification prob- lem. Creation of personalized models from passive smartphone data collected ‘in-the-wild’ to identify changes in HF severity appears possible. This new approach holds promise as a low burden and accurate method of monitoring HF symptoms, which could aid clinicians in early assessment and prevention of adverse outcomes.
Export to EndNote